PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1711147-0	1991	[Experimental studies on targeting chemotherapy using adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody].	Doxorubicin	54-64	alpha fetoprotein	Mus musculus	115-132	
1699858-1	1990	Combination therapy with hyperthermia and immuno-targeting chemotherapy was studied using conjugate of anti-AFP-antibody and adriamycin on AFP producing hepatocellular carcinoma (HC-4) in nude mice.	Doxorubicin	125-135	alpha fetoprotein	Mus musculus	139-142	
23961994-6	2013	RESULTS: Compared with Control, both PDOX and DOX could similarly and significantly reduce liver tumor weight and tumor volume by over 40%, ePCI values, retroperitoneal lymph node metastases and lung metastases and serum AFP levels (P < 0.05).	Doxorubicin	38-41	alpha fetoprotein	Mus musculus	221-224	
2440568-0	1987	Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody.	Doxorubicin	20-30	alpha fetoprotein	Mus musculus	81-98	
31141523-8	2019	The results showed that the level of alpha-fetoprotein was significantly reduced in PCA-ZnAl (350+-43.90 ng/mL), doxorubicin (DOX) (290+-20.52 ng/mL) and ZnAl-LDH (390+-19.65 ng/mL) treated animals compared to HCC mice treated with normal saline (580.4+- 52.04 ng/mL).	Doxorubicin	113-124	alpha fetoprotein	Mus musculus	37-54	
31141523-8	2019	The results showed that the level of alpha-fetoprotein was significantly reduced in PCA-ZnAl (350+-43.90 ng/mL), doxorubicin (DOX) (290+-20.52 ng/mL) and ZnAl-LDH (390+-19.65 ng/mL) treated animals compared to HCC mice treated with normal saline (580.4+- 52.04 ng/mL).	Doxorubicin	126-129	alpha fetoprotein	Mus musculus	37-54